查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786966

中樞神經系統治療市場，規模，佔有率，趨勢，產業分析報告:各疾病，各類藥物，各流通管道，各地區-2025～2034年市場預測

Central Nervous System Therapeutics Market Size, Share, Trends, & Industry Analysis Report, By Disease (Neurovascular Disease, CNS Trauma, Mental Health), By Drug Class, By Distribution Channel, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，中樞神經系統治療市場規模將達到 2,655.4 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

中樞神經系統 (CNS) 治療是指旨在控制和緩解影響大腦、脊髓和神經的疾病（例如憂鬱症、癲癇、帕金森氏症和阿茲海默症）的治療方法。這些治療方法包括藥物療法、生物製劑以及旨在改善神經功能和生活品質的新興數位醫療和精準醫療方法。

人口老化是中樞神經系統治療市場的主要驅動力之一。隨著人口老化，人們更容易患上神經系統和精神疾病，例如阿茲海默症、帕金森氏症和癡呆症。這些與年齡相關的疾病是慢性且進行性的，需要長期治療。北美、歐洲和亞洲部分地區不斷增長的老年人口，促使醫療保健系統提供更好、更有效率的中樞神經系統護理。此外，老年人更有可能尋求醫療協助並堅持治療計劃，從而對中樞神經系統疾病的治療和療法產生了穩定的需求。為此，製藥公司正專注於神經退化性疾病和與年齡相關的認知衰退的研究。各國政府也越來越多地資助老年醫療保健項目，包括針對中樞神經系統疾病的項目。全球老年人口的成長推動了醫療需求的成長，也刺激了對有效、便利和安全的中樞神經系統治療的需求。

後新冠疫情時代重新定義了醫療保健的優先事項，更加重視心理健康和神經系統護理。這場大流行不僅凸顯了在健康危機期間獲得中樞神經系統治療的脆弱性，而且增加了對數位療法、遠距治療模式以及管理慢性神經系統疾病的創新方法的需求。由於神經退化性疾病和精神疾病負擔日益加重，政府和私人機構也在增加對中樞神經系統（CNS）研究的投入，從而推動市場成長。

中樞神經系統治療市場報告重點

受憂鬱症、焦慮症、躁鬱症和精神分裂症等精神疾病全球成長的推動，預測期內精神健康領域的市場佔有率將達到 26.15%。

由於許多中樞神經系統治療，尤其是針對嚴重精神疾病和神經血管疾病的治療，都是在醫院內密切的醫療監督下進行或啟動的，因此醫院藥房領域的銷售額將在 2024 年達到 554.3 億美元。

受先進的醫療基礎設施、高昂的醫療成本以及人們對神經和精神疾病的廣泛認識的推動，北美中樞神經系統治療市場預計將在 2024 年佔據全球市場佔有率的 40.24%。

受人口規模龐大、醫療保健投資不斷增加以及人們對神經系統疾病認識不斷提高的推動，預計到 2024 年，亞太地區中樞神經系統治療市場的收入將達到 251.2 億美元。

全球主要市場參與者包括阿斯特捷利康公司、百健公司、禮來公司、強生公司和默克公司。

目錄

第1章 全球中樞神經系統治療市場報告概要

  • 調查範圍
  • 市場區隔分析
  • 各地區/國家的法規情勢
  • 市場投資情勢策略
  • 各疾病市場分析
    • 全球中樞神經系統治療市場佔有率(各疾病)(2025～2034年)
    • 神經血管疾病
    • 中樞神經系統外傷
    • 心理健康
    • 神經退化性疾病
      • 阿茲海默症
      • 帕金森氏症
      • 多發性硬化症
      • 亨丁頓舞蹈症
      • 肌肉萎縮性脊髓側索硬化症
      • 其他
    • 感染疾病
    • 中樞神經系統癌症
    • 其他
  • 2025年和2034年的各疾病中樞神經系統治療市場佔有率
  • 各類藥物市場分析
    • 全球中樞神經系統治療市場佔有率(各類藥物)(2025～2034年)
    • 麻醉劑
    • 抗痙攣藥
    • 制吐劑
    • 中樞神經刺激藥
    • 止痛藥
    • 其他
  • 2025年和2034年的全球中樞神經系統治療市場佔有率(各類藥物)
  • 各流通管道市場分析
    • 全球中樞神經系統治療市場佔有率(各流通管道)(2025～2034年)
    • 醫院藥局
    • 零售藥局
    • 其他
  • 2025年和2034年的流通管道的全球中樞神經系統治療市場佔有率

第2章 中樞神經系統治療市場上的動力拘束的課題與機會

  • 推動因素，抑制，課題，機會分析
    • 推動市場要素分析
    • 阻礙市場要素分析
    • 市場機會
    • 市場課題

第3章 全球經濟發展趨勢

  • 產業趨勢
    • SWOT分析
      • 優勢
      • 弱點
      • 機會
      • 威脅
    • PESTEL分析
      • 政治
      • 經濟
      • 社會
      • 技術
      • 環境
      • 法律
  • 潛在市場與成長潛在力分析

第4章 COVID-19影響

  • COVID-19影響
  • COVID V，U，W，L分析
    • COVID V分析
    • COVID U分析
    • COVID L分析
    • COVID-19分析

第5章 企業分析

  • 全球中樞神經系統治療市場，銷售地區，產品類型
  • 全球中樞神經系統治療市場的合併·收購，聯盟，產品銷售，合作
  • 企業清單

第6章 摘要整理

第7章 全球中樞神經系統治療市場預測，2021～2034年

第8章 全球中樞神經系統治療市場:各疾病(2021～2034年)

第9章 全球中樞神經系統治療市場:神經退化性疾病(2021～2034年)

第10章 全球中樞神經系統治療市場:各類藥物(2021～2034年)

第11章 全球中樞神經系統治療市場:各流通管道(2021～2034年)

第12章 全球中樞神經系統治療市場:各地區(2021～2034年)

第13章 北美的中樞神經系統治療市場:各國(2021～2034年)

第14章 北美的中樞神經系統治療市場:各疾病(2021～2034年)

第15章 北美的中樞神經系統治療市場:各類藥物(2021～2034年)

第16章 北美的中樞神經系統治療市場:各流通管道(2021～2034年)

第17章 美國的中樞神經系統治療市場:各疾病(2021～2034年)

第18章 美國的中樞神經系統治療市場:各類藥物(2021～2034年)

第19章 美國的中樞神經系統治療市場:各流通管道(2021～2034年)

第20章 加拿大的中樞神經系統治療市場:各疾病(2021～2034年)

第21章 加拿大的中樞神經系統治療市場:各類藥物(2021～2034年)

第22章 加拿大的中樞神經系統治療市場:各流通管道(2021～2034年)

第23章 歐洲的中樞神經系統治療市場:各國(2021～2034年)

第24章 歐洲的中樞神經系統治療市場:各疾病(2021～2034年)

第25章 歐洲的中樞神經系統治療市場:各類藥物(2021～2034年)

第26章 歐洲的中樞神經系統治療市場:各流通管道(2021～2034年)

第27章 英國的中樞神經系統治療市場:各疾病(2021～2034年)

第28章 英國的中樞神經系統治療市場:各類藥物(2021～2034年)

第29章 英國的中樞神經系統治療市場:各流通管道(2021～2034年)

第30章 德國的中樞神經系統治療市場:各疾病(2021～2034年)

第31章 德國的中樞神經系統治療市場:各類藥物(2021～2034年)

第32章 德國的中樞神經系統治療市場:各流通管道(2021～2034年)

第33章 法國的中樞神經系統治療市場:各疾病(2021～2034年)

第34章 法國的中樞神經系統治療市場:各類藥物(2021～2034年)

第35章 法國的中樞神經系統治療市場:各流通管道(2021～2034年)

第36章 西班牙的中樞神經系統治療市場:各疾病(2021～2034年)

第37章 西班牙的中樞神經系統治療市場:各類藥物(2021～2034年)

第38章 西班牙的中樞神經系統治療市場:各流通管道(2021～2034年)

第39章 義大利的中樞神經系統治療市場:各疾病(2021～2034年)

第40章 義大利的中樞神經系統治療市場:各類藥物(2021～2034年)

第41章 義大利的中樞神經系統治療市場:各流通管道(2021～2034年)

第42章 荷蘭的中樞神經系統治療市場:各疾病(2021～2034年)

第43章 荷蘭的中樞神經系統治療市場:各類藥物(2021～2034年)

第44章 荷蘭的中樞神經系統治療市場:各流通管道(2021～2034年)

第45章 俄羅斯的中樞神經系統治療市場:各疾病(2021～2034年)

第46章 俄羅斯的中樞神經系統治療市場:各類藥物(2021～2034年)

第47章 俄羅斯的中樞神經系統治療市場:各流通管道(2021～2034年)

第48章 其他的歐洲的中樞神經系統治療市場:各疾病(2021～2034年)

第49章 其他的歐洲的中樞神經系統治療市場:各類藥物(2021～2034年)

第50章 其他的歐洲的中樞神經系統治療市場:各流通管道(2021～2034年)

第51章 亞太地區的中樞神經系統治療市場:各國(2021～2034年)

第52章 亞太地區的中樞神經系統治療市場:各疾病(2021～2034年)

第53章 亞太地區的中樞神經系統治療市場:各類藥物(2021～2034年)

第54章 亞太地區的中樞神經系統治療市場:各流通管道(2021～2034年)

第55章 中國的中樞神經系統治療市場:各疾病(2021～2034年)

第56章 中國的中樞神經系統治療市場:各類藥物(2021～2034年)

第57章 中國的中樞神經系統治療市場:各流通管道(2021～2034年)

第58章 印度的中樞神經系統治療市場:各疾病(2021～2034年)

第59章 印度的中樞神經系統治療市場:各類藥物(2021～2034年)

第60章 印度的中樞神經系統治療市場:各流通管道(2021～2034年)

第61章 日本的中樞神經系統治療市場:各疾病(2021～2034年)

第62章 日本的中樞神經系統治療市場:各類藥物(2021～2034年)

第63章 日本的中樞神經系統治療市場:各流通管道(2021～2034年)

第64章 韓國的中樞神經系統治療市場:各疾病(2021～2034年)

第65章 韓國的中樞神經系統治療市場:各類藥物(2021～2034年)

第66章 韓國的中樞神經系統治療市場:各流通管道(2021～2034年)

第67章 印尼的中樞神經系統治療市場:各疾病(2021～2034年)

第68章 印尼的中樞神經系統治療市場:各類藥物(2021～2034年)

第69章 印尼的中樞神經系統治療市場:各流通管道(2021～2034年)

第70章 馬來西亞的中樞神經系統治療市場:各疾病(2021～2034年)

第71章 馬來西亞的中樞神經系統治療市場:各類藥物(2021～2034年)

第72章 馬來西亞的中樞神經系統治療市場:各流通管道(2021～2034年)

第73章 其他的亞太地區的中樞神經系統治療市場:各疾病(2021～2034年)

第74章 其他的亞太地區的中樞神經系統治療市場:各類藥物(2021～2034年)

第75章 其他的亞太地區的(2021～2034年)

第76章 南美中樞神經系統治療市場:各國(2021～2034年)

第77章 南美中樞神經系統治療市場:各疾病(2021～2034年)

第78章 南美中樞神經系統治療市場:各類藥物(2021～2034年)

第79章 南美中樞神經系統治療市場:各流通管道(2021～2034年)

第80章 巴西的中樞神經系統治療市場:各疾病(2021～2034年)

第81章 巴西的中樞神經系統治療市場:各類藥物(2021～2034年)

第82章 巴西的中樞神經系統治療市場:各流通管道(2021～2034年)

第83章 阿根廷中樞神經系統治療市場:各疾病(2021～2034年)

第84章 阿根廷的中樞神經系統治療市場:各類藥物(2021～2034年)

第85章 阿根廷中樞神經系統治療市場:各流通管道(2021～2034年)

第86章 墨西哥的中樞神經系統治療市場:各疾病(2021～2034年)

第87章 墨西哥的中樞神經系統治療市場:各類藥物(2021～2034年)

第88章 墨西哥的中樞神經系統治療市場:各流通管道(2021～2034年)

第89章 其他的南美中樞神經系統治療市場:各疾病(2021～2034年)

第90章 其他的南美中樞神經系統治療市場:各類藥物(2021～2034年)

第91章 其他的南美中樞神經系統治療市場:各流通管道(2021～2034年)

第92章 中東·非洲的中樞神經系統治療市場:各國(2021～2034年)

第93章 中東·非洲的中樞神經系統治療市場:各疾病(2021～2034年)

Product Code: PM5368

The central nervous system therapeutics market size is expected to reach USD 265.54 Billion by 2034, according to a new study by Polaris Market Research. The report "Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease (Neurovascular Disease, CNS Trauma, Mental Health), By Drug Class, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Central Nervous System (CNS) therapeutics refers to treatments aimed at managing and alleviating disorders affecting the brain, spinal cord, and nerves, such as depression, epilepsy, Parkinson's disease, and Alzheimer's. These therapies include medications, biologics, and emerging digital and precision medicine approaches designed to improve neurological function and quality of life.

An aging population is one of the strongest drivers of the CNS therapeutics market. People become more prone to neurological and mental health conditions like Alzheimer's, Parkinson's, and dementia as people age. These age-related disorders are chronic and progressive, requiring long-term medical attention and treatment. The rise in the elderly population globally in region such as North America, Europe, and parts of Asia is putting pressure on healthcare systems to provide better and more efficient CNS care. Older adults are also more likely to seek medical help and adhere to treatment plans, driving consistent demand for CNS drugs and therapies. In response, pharmaceutical companies are focusing their research efforts on neurodegenerative conditions and age-related cognitive decline. Governments are further increasing funding for elderly healthcare programs, including those targeting CNS disorders. The need for effective, accessible, and safe CNS therapeutics rise as the global senior population continues to grow, thereby driving the growth.

The post-COVID-19 landscape has redefined healthcare priorities, placing greater emphasis on mental well-being and neurological care. The pandemic not only highlighted the vulnerabilities in accessing CNS treatments during health crises but also increased demand for digital therapeutics, remote care models, and innovative approaches to managing chronic neurological conditions. Governments and private organizations are also investing more into CNS research, driven by the growing burden of neurodegenerative and psychiatric illnesses, thereby driving the growth.

Central Nervous System Therapeutics Market Report Highlights

The mental health segment accounted for 26.15% share during the forecast period driven by a global rise in psychiatric conditions such as depression, anxiety, bipolar disorder, and schizophrenia.

The hospital pharmacy segment accounted USD 55.43 billion revenue in 2024 as many CNS treatments, especially for severe mental health or neurovascular conditions, are administered or initiated in hospital settings under close medical supervision.

North America central nervous system therapeutics market accounted for 40.24% global market share in 2024 driven by advanced healthcare infrastructure, high healthcare spending, and widespread awareness of neurological and mental health conditions.

The Asia Pacific central nervous system therapeutics market recorded USD 25.12 billion revenue in 2024, due to its large population, rising healthcare investment, and increasing awareness of neurological disorders.

The global key market players are AstraZeneca plc; Biogen Inc.; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Neuraxpharm; Novartis AG; Otsuka Pharmaceutical Co., Ltd; Pfizer Inc.; Takeda Pharma Company Ltd; Teva Pharmaceutical Industries Ltd.

Polaris market research has segmented the central nervous system therapeutics market report based on Disease, drug class, distribution channel, and region:

By Disease (Revenue - USD Billion, 2020-2034)

Neurovascular Diseases

CNS Trauma

Mental Health

Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Huntington's Disease

Amyotrophic Lateral Sclerosis

Others

Infectious Diseases

CNS Cancer

Others

By Drug Class (Revenue - USD Billion, 2020-2034)

Anesthetics

Anticonvulsants

Antiemetic

CNS Stimulants

Pain Relievers

Others

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Other

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Table of Contents

1. Global Central Nervous System Therapeutics Market-Report Overview

  • 1.1. Scope of the report
  • 1.2. Market Segment Analysis
  • 1.3. Regulatory Scenario by Region/Country
  • 1.4. Market Investment Scenario Strategic
  • 1.5. Market Analysis by Disease (USD Million)
    • 1.5.1 Global Central Nervous System Therapeutics Market Share by Disease (2025-2034)
    • 1.5.2 Neurovascular Diseases
    • 1.5.3 CNS Trauma
    • 1.5.4 Mental Health
    • 1.5.5 Neurodegenerative Diseases
      • 1.5.5.1 Alzheimer's Disease
      • 1.5.5.2 Parkinson's Disease
      • 1.5.5.3 Multiple Sclerosis
      • 1.5.5.4 Huntington's Disease
      • 1.5.5.5 Amyotrophic Lateral Sclerosis
      • 1.5.5.6 Others
    • 1.5.6 Infectious Diseases
    • 1.5.7 CNS Cancer
    • 1.5.8 Others
  • 1.6. Global Central Nervous System Therapeutics Market Share by Disease in 2025 & 2034
  • 1.7. Market Analysis by Drug Class (USD Million)
    • 1.7.1 Global Central Nervous System Therapeutics Market Share by Drug Class (2025-2034)
    • 1.7.2 Anesthetics
    • 1.7.3 Anticonvulsants
    • 1.7.4 Antiemetic
    • 1.7.5 CNS Stimulants
    • 1.7.6 Pain Relievers
    • 1.7.7 Others
  • 1.8. Global Central Nervous System Therapeutics Market Share by Drug Class in 2025 & 2034
  • 1.9. Market Analysis by Distribution Channel (USD Million)
    • 1.9.1 Global Central Nervous System Therapeutics Market Share by Distribution Channel (2025-2034)
    • 1.9.2 Hospital Pharmacies
    • 1.9.3 Retail Pharmacies
    • 1.9.4 Others
  • 1.10. Global Central Nervous System Therapeutics Market Share by Distribution Channel in 2025 & 2034

2. driver restraint challenge and opportunities of Central Nervous System Therapeutics Market

  • 2.1. Driver, Restraint, Challenge and Opportunities Analysis
    • 2.1.1 Market Driver Analysis
    • 2.1.2 Market Restraint Analysis
    • 2.1.3 Market Opportunity
    • 2.1.4 Market Challenges

3. Global Growth Trends

  • 3.1. Industry Trends
    • 3.1.1 SWOT Analysis
      • 3.1.1.1 Strengths
      • 3.1.1.2 Weaknesses
      • 3.1.1.3 Opportunities
      • 3.1.1.4 Threats
    • 3.1.2 PESTEL Analysis
      • 3.1.2.1 Political Landscape
      • 3.1.2.2 Economic Landscape
      • 3.1.2.3 Social Landscape
      • 3.1.2.4 Technological Landscape
      • 3.1.2.5 Environmental Landscape
      • 3.1.2.6 Legal Landscape
    • 3.1.3 Porter's Five Forces Analysis
      • 3.1.3.1 Bargaining Power of Suppliers
      • 3.1.3.2 Bargaining Power of Buyers
      • 3.1.3.3 Threat of Substitute
      • 3.1.3.4 Threat of New Entrant
      • 3.1.3.5 Competitive Rivalry
  • 3.2. Potential Market and Growth Potential Analysis

4. Covid-19 Impact

  • 4.1. Covid-19 Impact
  • 4.2. COVID V, U, W and L Analysis
    • 4.2.1 COVID V Analysis
    • 4.2.2 COVID U Analysis
    • 4.2.3 COVID L Analysis
    • 4.2.4 COVID W Analysis

5. Companies Analysis

  • 5.1. Global Central Nervous System Therapeutics Market, Sales Area, Product Type
  • 5.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Central Nervous System Therapeutics Market
  • 5.3. Companies List

6. Exceutive Summary

7. Global Central Nervous System Therapeutics Market Forecast, 2021-2034, (USD Million)

  • 7.1. Global Central Nervous System Therapeutics Market

8. Global Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 8.1. Global Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 8.2. Global Central Nervous System Therapeutics Market by Disease (2028-2034)

9. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2034), (USD Million)

  • 9.1. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 9.2. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

10. Global Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 10.1. Global Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 10.2. Global Central Nervous System Therapeutics Market by Drug Class (2028-2034)

11. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 11.1. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 11.2. Global Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

12. Global Central Nervous System Therapeutics Market by REGION (2021-2034), (USD Million)

  • 12.1. Global Central Nervous System Therapeutics Market by Region (2021-2027)
  • 12.2. Global Central Nervous System Therapeutics Market by Region (2028-2034)

13. North America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 13.1. North America Central Nervous System Therapeutics Market by Country (2021-2027)
  • 13.2. North America Central Nervous System Therapeutics Market by Country (2028-2034)

14. North America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 14.1. North America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 14.2. North America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 14.3. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 14.4. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

15. North America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 15.1. North America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 15.2. North America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

16. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 16.1. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 16.2. North America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

17. United States Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 17.1. United States Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 17.2. United States Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 17.3. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 17.4. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

18. United States Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 18.1. United States Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 18.2. United States Central Nervous System Therapeutics Market by Drug Class (2028-2034)

19. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 19.1. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 19.2. United States Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

20. Canada Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 20.1. Canada Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 20.2. Canada Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 20.3. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 20.4. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

21. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 21.1. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 21.2. Canada Central Nervous System Therapeutics Market by Drug Class (2028-2034)

22. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 22.1. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 22.2. Canada Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

23. Europe Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 23.1. Europe Central Nervous System Therapeutics Market by Country (2021-2027)
  • 23.2. Europe Central Nervous System Therapeutics Market by Country (2028-2034)

24. Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 24.1. Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 24.2. Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 24.3. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 24.4. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

25. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 25.1. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 25.2. Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

26. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 26.1. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 26.2. Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

27. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 27.1. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 27.2. United Kingdom Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 27.3. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 27.4. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

28. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 28.1. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 28.2. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2028-2034)

29. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 29.1. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 29.2. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

30. Germany Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 30.1. Germany Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 30.2. Germany Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 30.3. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 30.4. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

31. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 31.1. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 31.2. Germany Central Nervous System Therapeutics Market by Drug Class (2028-2034)

32. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 32.1. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 32.2. Germany Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

33. France Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 33.1. France Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 33.2. France Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 33.3. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 33.4. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

34. France Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 34.1. France Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 34.2. France Central Nervous System Therapeutics Market by Drug Class (2028-2034)

35. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 35.1. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 35.2. France Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

36. Spain Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 36.1. Spain Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 36.2. Spain Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 36.3. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 36.4. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

37. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 37.1. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 37.2. Spain Central Nervous System Therapeutics Market by Drug Class (2028-2034)

38. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 38.1. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 38.2. Spain Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

39. Italy Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 39.1. Italy Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 39.2. Italy Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 39.3. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 39.4. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

40. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 40.1. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 40.2. Italy Central Nervous System Therapeutics Market by Drug Class (2028-2034)

41. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 41.1. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 41.2. Italy Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

42. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 42.1. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 42.2. Netherlands Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 42.3. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 42.4. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

43. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 43.1. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 43.2. Netherlands Central Nervous System Therapeutics Market by Drug Class (2028-2034)

44. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 44.1. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 44.2. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

45. Russia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 45.1. Russia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 45.2. Russia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 45.3. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 45.4. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

46. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 46.1. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 46.2. Russia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

47. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 47.1. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 47.2. Russia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

48. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 48.1. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 48.2. Rest of Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 48.3. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 48.4. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

49. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 49.1. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 49.2. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

50. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 50.1. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 50.2. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

51. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 51.1. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2027)
  • 51.2. Asia Pacific Central Nervous System Therapeutics Market by Country (2028-2034)

52. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 52.1. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 52.2. Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 52.3. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 52.4. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

53. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 53.1. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 53.2. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

54. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 54.1. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 54.2. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

55. China Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 55.1. China Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 55.2. China Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 55.3. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 55.4. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

56. China Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 56.1. China Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 56.2. China Central Nervous System Therapeutics Market by Drug Class (2028-2034)

57. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 57.1. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 57.2. China Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

58. India Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 58.1. India Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 58.2. India Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 58.3. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 58.4. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

59. India Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 59.1. India Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 59.2. India Central Nervous System Therapeutics Market by Drug Class (2028-2034)

60. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 60.1. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 60.2. India Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

61. Japan Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 61.1. Japan Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 61.2. Japan Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 61.3. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 61.4. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

62. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 62.1. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 62.2. Japan Central Nervous System Therapeutics Market by Drug Class (2028-2034)

63. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 63.1. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 63.2. Japan Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

64. South Korea Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 64.1. South Korea Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 64.2. South Korea Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 64.3. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 64.4. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

65. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 65.1. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 65.2. South Korea Central Nervous System Therapeutics Market by Drug Class (2028-2034)

66. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 66.1. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 66.2. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

67. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 67.1. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 67.2. Indonesia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 67.3. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 67.4. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

68. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 68.1. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 68.2. Indonesia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

69. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 69.1. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 69.2. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

70. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 70.1. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 70.2. Malaysia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 70.3. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 70.4. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

71. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 71.1. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 71.2. Malaysia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

72. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 72.1. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 72.2. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

73. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 73.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 73.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 73.3. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 73.4. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

74. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 74.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 74.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

75. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 75.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 75.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

76. Latin America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 76.1. Latin America Central Nervous System Therapeutics Market by Country (2021-2027)
  • 76.2. Latin America Central Nervous System Therapeutics Market by Country (2028-2034)

77. Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 77.1. Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 77.2. Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 77.3. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 77.4. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

78. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 78.1. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 78.2. Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

79. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 79.1. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 79.2. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

80. Brazil Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 80.1. Brazil Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 80.2. Brazil Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 80.3. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 80.4. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

81. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 81.1. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 81.2. Brazil Central Nervous System Therapeutics Market by Drug Class (2028-2034)

82. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 82.1. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 82.2. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

83. Argentina Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 83.1. Argentina Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 83.2. Argentina Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 83.3. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 83.4. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

84. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 84.1. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 84.2. Argentina Central Nervous System Therapeutics Market by Drug Class (2028-2034)

85. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 85.1. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 85.2. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

86. Mexico Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 86.1. Mexico Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 86.2. Mexico Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 86.3. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 86.4. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

87. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 87.1. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 87.2. Mexico Central Nervous System Therapeutics Market by Drug Class (2028-2034)

88. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 88.1. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 88.2. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

89. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 89.1. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 89.2. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 89.3. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 89.4. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

90. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 90.1. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 90.2. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

91. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 91.1. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 91.2. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

92. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 92.1. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2027)
  • 92.2. Middle East & Africa Central Nervous System Therapeutics Market by Country (2028-2034)

93. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 93.1. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 93.2. Middle East & Africa Central Nervous System Therapeutics Market

LIST OF TABLES

  • TABLE 1. Market SEGMENT
  • TABLE 2. Global Central Nervous System Therapeutics Market Growth Rate by Disease (USD Million) (2025-2034)
  • TABLE 3. Global Central Nervous System Therapeutics Market Growth Rate by Neurodegenerative Diseases (USD Million) (2025-2034)
  • TABLE 4. Global Central Nervous System Therapeutics Market Growth Rate by Drug Class (USD Million) (2025-2034)
  • TABLE 5. Global Central Nervous System Therapeutics Market Growth Rate by DISTRIBUTION CHANNEL (USD Million) (2025-2034)
  • TABLE 6. Global Central Nervous System Therapeutics Market - Market snapshot & key buying criteria, 2025 - 2034
  • TABLE 7. Global Central Nervous System Therapeutics MARKET SIZE (USD Million), (USD MILLION) (2021-2027)
  • TABLE 8. Global Central Nervous System Therapeutics MARKET SIZE (USD Million), (USD MILLION) (2028-2034)
  • TABLE 9. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISEASE, (2021-2027)
  • TABLE 10. Global Central Nervous System Therapeutics Market SHARE BY DISEASE, (2021-2027)
  • TABLE 11. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISEASE, (2028-2034)
  • TABLE 12. Global Central Nervous System Therapeutics Market SHARE BY DISEASE, (2028-2034)
  • TABLE 13. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY NEURODEGENERATIVE DISEASES, (2021-2027)
  • TABLE 14. Global Central Nervous System Therapeutics Market SHARE BY NEURODEGENERATIVE DISEASES, (2021-2027)
  • TABLE 15. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY NEURODEGENERATIVE DISEASES, (2028-2034)
  • TABLE 16. Global Central Nervous System Therapeutics Market SHARE BY NEURODEGENERATIVE DISEASES, (2028-2034)
  • TABLE 17. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DRUG CLASS, (2021-2027)
  • TABLE 18. Global Central Nervous System Therapeutics Market SHARE BY DRUG CLASS, (2021-2027)
  • TABLE 19. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DRUG CLASS, (2028-2034)
  • TABLE 20. Global Central Nervous System Therapeutics Market SHARE BY DRUG CLASS, (2028-2034)
  • TABLE 21. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISTRIBUTION CHANNEL, (2021-2027)
  • TABLE 22. Global Central Nervous System Therapeutics Market SHARE BY DISTRIBUTION CHANNEL, (2021-2027)
  • TABLE 23. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISTRIBUTION CHANNEL, (2028-2034)
  • TABLE 24. Global Central Nervous System Therapeutics Market SHARE BY DISTRIBUTION CHANNEL, (2028-2034)
  • TABLE 25. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Region, (2021-2027)
  • TABLE 26. Global Central Nervous System Therapeutics Market SHARE BY Region, (2021-2027)
  • TABLE 27. Global Central Nervous System Therapeutics marke SIZE BY Region, (2028-2034)
  • TABLE 28. Global Central Nervous System Therapeutics Market SHARE BY Region, (2028-2034)
  • TABLE 29. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 30. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 31. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 32. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 33. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 34. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 35. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 36. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 37. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 38. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 39. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 40. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 41. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 42. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 43. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 44. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 45. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 46. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 47. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 48. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 49. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 50. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 51. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 52. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 53. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 54. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 55. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 56. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 57. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 58. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 59. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 60. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 61. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 62. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 63. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 64. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 65. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 66. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 67. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 68. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 69. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 70. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 71. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 72. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 73. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 74. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 75. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 76. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 77. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 78. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 79. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 80. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 81. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 82. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 83. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 84. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 85. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 86. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 87. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 88. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 89. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 90. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 91. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 92. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 93. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 94. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 95. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 96. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 97. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 98. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 99. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 100. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 101. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 102. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 103. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 104. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 105. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 106. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 107. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 108. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 109. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 110. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 111. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 112. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 113. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 114. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 115. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 116. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 117. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 118. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 119. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 120. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 121. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 122. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 123. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 124. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 125. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 126. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 127. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 128. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 129. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 130. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 131. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 132. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 133. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 134. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 135. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 136. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 137. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 138. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 139. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 140. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 141. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 142. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 143. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 144. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 145. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 146. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 147. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 148. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 149. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 150. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 151. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 152. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 153. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 154. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 155. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 156. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 157. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 158. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 159. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 160. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 161. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 162. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 163. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 164. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 165. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 166. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 167. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 168. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 169. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 170. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 171. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 172. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 173. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 174. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 175. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 176. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 177. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 178. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 179. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 180. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 181. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 182. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 183. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 184. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 185. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 186. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 187. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 188. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 189. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 190. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 191. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 192. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 193. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 194. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 195. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 196. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 197. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 198. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 199. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 200. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 201. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 202. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 203. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 204. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 205. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 206. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 207. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 208. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 209. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 210. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 211. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 212. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 213. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 214. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 215. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 216. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 217. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 218. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 219. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 220. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 221. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 222. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 223. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 224. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 225. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 226. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 227. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 228. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 229. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 230. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 231. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 232. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 233. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 234. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 235. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 236. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 237. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 238. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 239. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 240. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 241. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 242. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 243. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 244. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 245. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 246. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 247. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 248. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 249. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 250. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 251. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 252. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 253. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 254. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 255. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 256. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 257. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 258. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 259. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 260. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 261. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 262. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 263. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 264. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 265. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 266. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 267. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 268. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 269. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 270. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 271. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 272. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 273. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 274. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 275. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 276. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 277. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 278. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 279. Rest of Middle East & Africa Central Nervous System Therapeutics MARKET